Form 4: Aveanna Healthcare CEO Jeff Shaner Reports Significant Stock Vesting and Tax-Related Share Disposition

Aveanna Healthcare Holdings, Inc. CEO Jeff Shaner reported the vesting of performance-based restricted stock units, resulting in the acquisition of 139,665 shares and the disposition of 63,618 shares for tax purposes on June 5, 2025.

Summary

• Jeff Shaner, Chief Executive Officer of Aveanna Healthcare Holdings, Inc. (AVAH), reported transactions involving the company's common stock.
• On June 5, 2025, Mr. Shaner acquired 139,665 shares of common stock at a price of $0.00 per share. These shares represent the vesting of performance-based restricted stock units (RSUs) issued pursuant to the Company's Senior Management Retention Plan.
• Concurrently, on June 5, 2025, Mr. Shaner disposed of 63,618 shares of common stock at a price of $5.51 per share. This disposition was not an open market transaction but rather shares withheld by the company for the payment of taxes upon the vesting of the RSUs.
• Following these transactions, Mr. Shaner beneficially owns 2,477,639 shares of Aveanna Healthcare Holdings, Inc. common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged plan for the purchase or sale of equity securities.

Sentiment

Score: 7

Explanation: The document reports a routine executive compensation event (RSU vesting) and a tax-related share disposition. The vesting of performance-based units is generally positive as it implies performance targets were met. The disposition is for tax purposes and not an open market sale, so it doesn't indicate a negative sentiment from the insider. Overall, it's a neutral to slightly positive event reflecting compensation structure.

Positives

• The acquisition of 139,665 shares indicates the vesting of performance-based restricted stock units, suggesting that performance targets were met.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent transaction.

Negatives

• The disposition of 63,618 shares, although for tax purposes, reduces the direct beneficial ownership of the CEO.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details a routine insider transaction related to executive compensation. The vesting of performance-based restricted stock units and subsequent tax-related share withholding are common practices in executive compensation across various industries, including healthcare, designed to align executive incentives with company performance.

Comparison to Industry Standards

• The vesting of performance-based restricted stock units and subsequent tax-related share withholding is a standard practice in executive compensation across various industries, including healthcare. It aligns with common incentive structures designed to align executive interests with shareholder value creation.
• No specific comparable companies, projects, or results are mentioned in this filing for direct comparison.

Stakeholder Impact

• Shareholders: The vesting of performance-based RSUs suggests that the company met certain performance criteria, which could be viewed positively. The CEO's continued significant ownership aligns his interests with shareholders.

Key Dates

Keywords

Aveanna Healthcare Holdings, AVAH, Jeff Shaner, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, CEO Stock Ownership, Performance-Based Compensation, Rule 10b5-1